Mylan shares to rally nearly 60 percent as EpiPen controversy fades: Raymond James

Facebook
ВКонтакте
share_fav

Raymond James on Monday upgraded shares of Mylan to strong buy from market perform, citing valuations that have reached a multidecade low.

посмотреть на CNBC: Top News